Does rotavirus turn on type 1 diabetes?

English version

Autoři: Leonard C. Harrison ^aff001; Kirsten P. Perrett ^aff002; Kim Jachno ^aff003; Terry M. Nolan ^aff002; Margo C. Honeyman ^aff001
Působiště autorů: Walter and Eliza Hall Institute for Medical Research, University of Melbourne, Melbourne, Victoria, Australia ^aff001; Vaccine and Immunization Research Group, Murdoch Children’s Research Institute and the Melbourne School of Population and Global Health, University of Melbourne, Parkville, Victoria, Australia ^aff002; Clinical Epidemiology and Biostatistics Unit, Murdoch Children's Research Institute, Parkville, Victoria, Australia ^aff003
Vyšlo v časopise: Does rotavirus turn on type 1 diabetes?. PLoS Pathog 15(10): e32767. doi:10.1371/journal.ppat.1007965
Kategorie: Pearls
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1007965

Zdroje

1. Burnett E, Jonesteller CL, Tate JE, Yen C, Parashar UD. Global impact of rotavirus vaccination on childhood hospitalizations and mortality from diarrhea. J Infect Dis. 2017 Jun 1;215(11):1666–72. doi: 10.1093/infdis/jix186 28430997

2. Perrett KP, Jachno K, Nolan TM, Harrison LC. Association of rotavirus vaccination and the incidence of type 1 diabetes in children. JAMA Pediatr. 2019 Jan 22; 173:280–82. doi: 10.1001/jamapediatrics.2018.4578 30667473

3. Perrett KP, Jachno K, Nolan TM, Harrison LC. Coding error in study of rotavirus vaccination and type 1 diabetes in children. JAMA Pediatr. 2019 July 15; doi: 10.1001/jamapediatrics.2019.2463 31305930

4. Brusic V, Rudy G, Kyne AP, Harrison LC. MHCPEP—a database of MHC-binding peptides: Update 1995. Nucl Acid Res. 1996 Jan 1;24(1):242–44. doi: 10.1093/nar/24.1.242 8594590

5. Harrison LC, Honeyman MC, Trembleau S, Gregori S, Gallazzi F, Augstein P, et al. A peptide binding motif for I-Ag7, the class II MHC molecule of NOD and Biozzi ABH mice. J Exp Med. 1997 Mar 17;185(6):1013–21. doi: 10.1084/jem.185.6.1013 9091575

6. Brusic V, Rudy G, Honeyman MC, Hammer J, Harrison LC. Prediction of MHC class II-binding peptides using an evolutionary algorithm and artificial neural network. Bioinformatics. 1998;14(2):121–30. doi: 10.1093/bioinformatics/14.2.121 9545443

7. Honeyman MC, Stone NL, Harrison LC. T-cell epitopes in the type 1 diabetes autoantigen tyrosine phosphatase IA-2: potential for mimicry with rotavirus and other environmental agents. Mol Medicine. 1998 Apr;4(4):231–239. 9606176

8. Honeyman MC, Brusic V, Stone N, Harrison LC. Neural network-based prediction of candidate T-cell epitopes. Nature Biotech. 1998 Oct;16(10):966–70. doi: 10.1038/nbt1098-966 9788355

9. Honeyman MC, Stone NL, Falk BA, Nepom G, Harrison LC. Evidence for molecular mimicry between human T cell epitopes in rotavirus and pancreatic islet autoantigens. J Immunol. 2010 Feb 15;184(4): 2204–10. doi: 10.4049/jimmunol.0900709 20083660

10. Martinuzzi E, Novelli G, Scotto M, Blancou P, Bach JM, Chaillous L, et al. The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment. Diabetes. 2008 May;57(5):1312–20. doi: 10.2337/db07-1594 18305140

11. Roczo-Farkas S, Kirkwood CD, Cowley D, Barnes GL, Bishop RF, Bogdanovic-Sakran N, et al. The impact of rotavirus vaccines on genotype diversity: a comprehensive analysis of 2 decades of Australian surveillance data. J Infect Dis. 2018 July;218(4):546–54. doi: 10.1093/infdis/jiy197 29790933

12. Honeyman MC, Coulson BS, Stone NL, Gellert SA, Goldwater PN, Steele CE, et al. Association between rotavirus infection and pancreatic islet autoimmunity in children at-risk for type 1 diabetes. Diabetes. 2000 Aug;49(8):1319–24. doi: 10.2337/diabetes.49.8.1319 10923632

13. Coulson BS, Witterick PD, Hewish MJ, Mountford JN, Harrison LC, Honeyman MC. Growth of rotaviruses in primary pancreatic cells. J Virol. 2002 Sept;76(18): 9537–44. doi: 10.1128/JVI.76.18.9537-9544.2002 12186936

14. Onodera T, Jenson AB, Yoon JW, Notkins AL. Virus-induced diabetes mellitus: reovirus infection of pancreatic beta cells in mice. Science. 1978 Aug 11;201(4355):529–31. doi: 10.1126/science.208156 208156

15. Campbell IL, Harrison LC, Ashcroft RG, Jack I. Reovirus infection enhances expression of class I MHC proteins on human beta-cell and rat RINm5F cell. Diabetes. 1988 Mar;37(3):362–65. doi: 10.2337/diab.37.3.362 2836251

16. Honeyman MC, Laine D, Londrigan S, Kirkwood C, Harrison LC. Rotavirus infection induces transient pancreatic involution and hyperglycemia in weanling mice. PLoS ONE. 2014 Sept 2;9(9); e106560. doi: 10.1371/journal.pone.0106560 25181416

17. Harrison LC, Honeyman MC, Morahan G, Wentworth JM, Elkassaby S, Colman PG, et al. Type 1 diabetes: lessons for other autoimmune diseases? J Autoimmun. 2008 Nov;31(3):306–10. doi: 10.1016/j.jaut.2008.04.026 18558477

18. Graham KL, O'Donnell JA, Tan Y, Sanders N, Carrington EM, Allison J, et al. Rotavirus infection of infant and young adult non-obese diabetic mice involves extraintestinal spread and delays diabetes onset. J Virol. 2007 Jun;81(12):6446–58. doi: 10.1128/JVI.00205-07 17428851

19. Graham KL, Sanders N, Tan Y, Allison J, Kay TW, Coulson BS. Rotavirus infection accelerates type 1 diabetes in mice with established insulitis. J Virol. 2008 Jul;82(13):6139–49. doi: 10.1128/JVI.00597-08 18417562

20. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes. 1965 Oct;14(10):619–33. doi: 10.2337/diab.14.10.619 5318831

21. Campbell-Thompson M, Wasserfall C, Montgomery EL, Atkinson MA, Kaddis JA. Pancreas organ weight in individuals with disease-associated autoantibodies at risk for type 1 diabetes. JAMA. 2012 Dec 12;308(22):2337–39. doi: 10.1001/jama.2012.15008 23232891

22. Gale EA. The rise of childhood type 1 diabetes in the 20th century. Diabetes. 2002 Dec;51(12):3353–61. doi: 10.2337/diabetes.51.12.3353 12453886

23. Fourlanos S, Varney M, Tait BD, Morahan G, Honeyman MC, Colman PG, et al. The rising incidence of type 1 diabetes is accounted for by cases with lower risk HLA genotypes. Diabetes Care. 2008 Aug;31(8):1546–49. doi: 10.2337/dc08-0239 18487476

24. Reyes JF, Wood JG, Beutels P, Macartney K, McIntyre P, Menzies R, et al. Beyond expectations: Post-implementation data shows rotavirus vaccination is likely cost-saving in Australia. Vaccine. 2017 Jan 5;35(2):345–52. doi: 10.1016/j.vaccine.2016.11.056 27916411

25. Matthijnssens J, Joelsson DB, Warakomski DJ, Zhou T, Mathis PK, van Maanen MH, et al. Molecular and biological characterization of the 5 human-bovine rotavirus (WC3)-based reassortant strains of the pentavalent rotavirus vaccine, RotaTeq. Virology. 2010 Aug 1;403(2):111–27. doi: 10.1016/j.virol.2010.04.004 20451234

26. Rogers MAM, Basu T, Kim C. Lower incidence rate of type 1 diabetes after receipt of the rotavirus vaccine in the United States, 2001–2017. Sci Rep. 2019 Jun 13;9(1):7727. doi: 10.1038/s41598-019-44193-4 31197227.

27. Vaarala O, Jokinen J, Lahdenkari M, Leino T. Rotavirus vaccination and the risk of celiac disease or type 1 diabetes in Finnish children at early life. Pediatr Infect Dis J. 2017 Jul;36(7)674–75. doi: 10.1097/INF.0000000000001600 28399059